PriceTargets.com logo

Beyond Air - XAIR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.50
  • Forecasted Upside: 250.16%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$6.14 As of 03/24/2023 01:00 AM ET
▼ -0.15 (-2.38%)

This chart shows the closing price for XAIR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Beyond Air Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XAIR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XAIR

Analyst Price Target is $21.50
▲ +250.16% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Beyond Air in the last 3 months. The average price target is $21.50, with a high forecast of $23.00 and a low forecast of $20.00. The average price target represents a 250.16% upside from the last price of $6.14.

This chart shows the closing price for XAIR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Beyond Air. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/1/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/28/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/26/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/25/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/29/2022Truist FinancialBoost TargetBuy$16.00 ➝ $20.00Low
6/29/2022LADENBURG THALM/SH SHBoost TargetBuy$17.00 ➝ $23.00Low
11/15/2021Roth CapitalBoost TargetBuy$11.00 ➝ $15.00Low
11/12/2021Truist FinancialBoost TargetBuy$12.00 ➝ $16.00High
11/12/2021OppenheimerBoost TargetOutperform$9.00 ➝ $13.00High
6/22/2021Roth CapitalReiterated RatingBuyC$11.00Low
6/22/2021LADENBURG THALM/SH SHReiterated RatingBuyC$17.00Low
6/18/2021OppenheimerReiterated RatingBuy$9.00High
6/15/2021Roth CapitalReiterated RatingBuyMedium
4/28/2021Truist FinancialInitiated CoverageBuy$12.00High
9/22/2020OppenheimerReiterated RatingBuy$9.00High
6/23/2020OppenheimerReiterated RatingBuy$9.00Medium
10/22/2019OppenheimerInitiated CoverageOutperform$9.00 ➝ $9.00High
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/28/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
10/27/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/26/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
12/26/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
1/25/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
2/24/2023
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Beyond Air logo
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. It engages in developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. It operates under the Beyond Air and Beyond Cancer segments. The firm developed the LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. The company was founded in 2011 and is headquartered in Garden City, NY.
Read More

Today's Range

Now: $6.14
Low: $5.82
High: $6.29

50 Day Range

MA: $6.41
Low: $5.65
High: $7.56

52 Week Range

Now: $6.14
Low: $4.78
High: $11.76

Volume

707,715 shs

Average Volume

302,437 shs

Market Capitalization

$184.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Beyond Air?

The following sell-side analysts have issued stock ratings on Beyond Air in the last year: LADENBURG THALM/SH SH, and Truist Financial Co..
View the latest analyst ratings for XAIR.

What is the current price target for Beyond Air?

2 Wall Street analysts have set twelve-month price targets for Beyond Air in the last year. Their average twelve-month price target is $21.50, suggesting a possible upside of 250.2%. LADENBURG THALM/SH SH has the highest price target set, predicting XAIR will reach $23.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $20.00 for Beyond Air in the next year.
View the latest price targets for XAIR.

What is the current consensus analyst rating for Beyond Air?

Beyond Air currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe XAIR will outperform the market and that investors should add to their positions of Beyond Air.
View the latest ratings for XAIR.

What other companies compete with Beyond Air?

Other companies that are similar to Beyond Air include ClearPoint Neuro, Alpha Tau Medical, CVRx, Meihua International Medical Technologies and TELA Bio. Learn More about companies similar to Beyond Air.

How do I contact Beyond Air's investor relations team?

Beyond Air's physical mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company's listed phone number is (516) 665-8200. The official website for Beyond Air is www.beyondair.net. Learn More about contacing Beyond Air investor relations.